Ko Naomi, Oshry Lauren, Lederman Ruth, Gagnon Haley, Fikre Tsion, Gundersen Daniel, Revette Anna, Odai-Afotey Ashley, Kantor Olga, Hershman Dawn, Crew Katherine, Keating Nancy, Freedman Rachel
Boston University School of Medicine/Boston Medical Center.
Dana-Farber Cancer Institute.
Res Sq. 2024 Sep 20:rs.3.rs-4837604. doi: 10.21203/rs.3.rs-4837604/v1.
Discrimination can contribute to worse health outcomes, but its prevalence in breast cancer is not well studied. We aimed to understand how women with stage I-III breast cancer faced discrimination in health care and everyday settings through a cross-sectional survey. 296 women, 178 (60%) Non-Hispanic White (NHW), 76 (26%) Non-Hispanic Black (NHB), and 42 (14%) Hispanic participated. NHB women reported significantly more discrimination in everyday life compared to NHW women (score 20.1 vs 16.1, p<.001) and Hispanic women (score 20.1 vs 16.0, p<.001). In the health care setting, NHB had statistically more frequent reports of being ignored (23.7% vs. 5.6%), treated with less respect (21.1% vs. 7.3%), and treated with less courtesy (18.7% vs. 6.2%; all P=<.001) when compared to NHW women. NHB women experience a higher degree of discrimination both inside and outside of health care. Further research to understand discrimination on breast cancer outcomes is warranted.
歧视会导致更差的健康结果，但在乳腺癌患者中的普遍程度尚未得到充分研究。我们旨在通过一项横断面调查，了解I-III期乳腺癌女性在医疗保健和日常生活中如何遭遇歧视。296名女性参与了调查，其中178名（60%）为非西班牙裔白人（NHW），76名（26%）为非西班牙裔黑人（NHB），42名（14%）为西班牙裔。与NHW女性相比，NHB女性在日常生活中报告遭受的歧视明显更多（得分20.1对16.1，p<.001），与西班牙裔女性相比也是如此（得分20.1对16.0，p<.001）。在医疗保健环境中，与NHW女性相比，NHB女性在统计上更频繁地报告被忽视（23.7%对5.6%）、受到较少尊重（21.1%对7.3%）和受到较少礼貌对待（18.7%对6.2%；所有P<0.001）。NHB女性在医疗保健内外都经历了更高程度的歧视。有必要进行进一步的研究以了解歧视对乳腺癌结果的影响。
